← Back to Search

Behavioural Intervention

Communication Strategies for ALS

N/A
Recruiting
Led By Navin Viswanathan, PhD
Research Sponsored by Penn State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one 60 minute session
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study how talking to others affects the ability to communicate verbally in individuals with ALS compared to those without ALS. Participants will be asked to read words and sentences both alone and while interacting with

Who is the study for?
This trial is for people with ALS who can still speak single words and are native American English speakers. They should have no other speech, language, or neurological issues besides ALS, no history of conditions like stroke, and must pass a cognitive assessment as well as a hearing test.
What is being tested?
The study examines the impact of different types of communicative interactions on verbal communication in individuals with ALS. Participants will read words and sentences alone and then in an interactive setting to compare effects.
What are the potential side effects?
Since this trial focuses on communication methods rather than medical treatments, there are no direct side effects related to drugs or procedures. However, participants may experience fatigue or emotional distress during the tasks.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one 60 minute session
This trial's timeline: 3 weeks for screening, Varies for treatment, and one 60 minute session for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Duration of speech sounds
Formant frequencies of speech sounds
Intelligibility of recorded speech
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: People with amyotrophic lateral sclerosis, age-matched speakersExperimental Treatment4 Interventions
People with ALS and age-matched speakers will participate in structured communicative interaction.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Clear Speech
2021
N/A
~40

Find a Location

Who is running the clinical trial?

Penn State UniversityLead Sponsor
370 Previous Clinical Trials
127,705 Total Patients Enrolled
1 Trials studying Amyotrophic Lateral Sclerosis
170 Patients Enrolled for Amyotrophic Lateral Sclerosis
Navin Viswanathan, PhDPrincipal InvestigatorThe Pennsylvania State University
Jimin Lee, PhDPrincipal InvestigatorThe Pennsylvania State University
Anne Olmstead, PhDPrincipal InvestigatorThe Pennsylvania State University
~200 spots leftby Mar 2029
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top